2014
DOI: 10.5020/18061230.2014.p198
|View full text |Cite
|
Sign up to set email alerts
|

Uso de antimicrobianos por gestantes no serviço público de saúde

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
1
0
11

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 9 publications
0
1
0
11
Order By: Relevance
“…Studies reveal that the use of any medication during pregnancy cannot be indiscriminate because of the potential risks and damage caused by their toxicity to the fetus (12)(13) . In fact, there is evidence that the greater the use of antibiotics during pregnancy, the greater the change in the heterogeneity of the intestinal flora of newborns and the colonization by certain pathogens (14) . The antihypertensive drugs deserve attention because they are related to the treatment of gestational hypertension that increases the risk of perinatal morbidity and mortality (15) .…”
Section: Discussionmentioning
confidence: 99%
“…Studies reveal that the use of any medication during pregnancy cannot be indiscriminate because of the potential risks and damage caused by their toxicity to the fetus (12)(13) . In fact, there is evidence that the greater the use of antibiotics during pregnancy, the greater the change in the heterogeneity of the intestinal flora of newborns and the colonization by certain pathogens (14) . The antihypertensive drugs deserve attention because they are related to the treatment of gestational hypertension that increases the risk of perinatal morbidity and mortality (15) .…”
Section: Discussionmentioning
confidence: 99%
“…Estudos avaliando a adesão de usuários do SUS a medicamentos essenciais têm demonstrado grande variabilidade (CINTRA; GUARLENTO; MIYASAKI) (GARCIA-PÉREZ et al, 2000) (GIROTO et al, 2013. Estudo recente avaliou a adesão de pacientes usuários do CEAF e observou alta prevalência de barreiras de adesão, principalmente barreiras de recordação (FRITZEN;MOTTER;PANIZ, 2017).…”
Section: Introductionunclassified
“…Estudos avaliando a adesão de usuários do SUS a medicamentos essenciais têm demonstrado grande variabilidade (CINTRA; GUARLENTO; MIYASAKI) (GARCIA-PÉREZ et al, 2000) (GIROTO et al, 2013. Estudo recente avaliou a adesão de pacientes usuários do CEAF e observou alta prevalência de barreiras de adesão, principalmente barreiras de recordação (FRITZEN;MOTTER;PANIZ, 2017).…”
Section: Introductionunclassified